JP Morgan Chase
DMII

JP Morgan Chase’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

JP Morgan Chase’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Buy
555,951
+426,321
+329% +$4.28M ﹤0.01% 3358
2026
Q1 		$1.29M Hold
129,630
– – ﹤0.01% 4427
2025
Q4 		$1.28M Buy
+129,630
New +$1.28M ﹤0.01% 4426

Other funds holding DMII

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

JP Morgan Chase's DMII Position: Q2 2026 in Review

JP Morgan Chase increased its Drugs Made In America Acquisition II Corp (DMII) stake by 329% in Q2 2026, buying an estimated $4.28M and bringing the position to 555,951 shares worth $5.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3358.

JP Morgan Chase first reported a position in DMII in Q4 2025 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • JP Morgan Chase held 555,951 shares of Drugs Made In America Acquisition II Corp worth $5.6M as of Q2 2026.
  • JP Morgan Chase bought 426,321 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $4.28M.
  • Drugs Made In America Acquisition II Corp made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3358 holding.
  • JP Morgan Chase first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.